Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease. In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story.
This podcast is powered by DeviceTalks and is part of the DeviceTalks Podcast Network.
All content for Structural Heart Talks: Edwards Lifesciences is the property of DeviceTalks Podcast Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease. In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story.
This podcast is powered by DeviceTalks and is part of the DeviceTalks Podcast Network.
Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact
Structural Heart Talks: Edwards Lifesciences
22 minutes 23 seconds
6 months ago
Edwards surgical structural heart SVP Markowitz highlights culture, innovation, and making an impact
In this episode of Structural Heart Talks, Wayne Markowitz, General Manager and SVP, Surgical Structural Heart at Edwards Lifesciences, discussed the evolving landscape of the structural heart space, emphasizing the sharpened focus at Edwards under new leadership.
Markowitz highlights the importance of the surgical structural heart business, with a strong emphasis on innovation and collaboration with cardiac surgeons. He emphasizes Edwards’ 65-year legacy in innovation driven by partnerships with the surgical community, focusing on addressing unmet patient needs. The conversation also touched on the RESILIA portfolio, featuring surgical valves and conduits, and highlights ongoing clinical trials.
Looking ahead, Markowitz shares his optimism about the future of the surgical structural heart business, emphasizing the need to bring more patients into the treatment system and the potential for growth in emerging markets.
Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8
Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to Structural Heart Talks wherever you get your podcasts and follow youtube.com/@DeviceTalks.
Structural Heart Talks is a powered by DeviceTalks, part of the DeviceTalks Podcast Network.
Structural Heart Talks: Edwards Lifesciences
Over 60 years ago, engineer Miles Lowell Edwards and surgeon Dr. Albert Starr launched a company and an industry by developing the first commercially available artificial heart valve. Today, Edwards Lifesciences is focusing its attention on developing life-saving and groundbreaking devices that can help patients with heart valve disease. In this podcast series, we'll talk with the Edwards Lifesciences leaders who are adding to this great MedTech story.
This podcast is powered by DeviceTalks and is part of the DeviceTalks Podcast Network.
